[SPECIAL EDITION - VIDEO] AI vs. Cancer & Incurable Disease: What Google, Anthropic, OpenAI, Microsoft & Isomorphic Have Actually Proven (Oct 13, 2026)
Every major AI lab now says it's fighting disease. We checked the claims against the original research. The AI-discovered drug furthest along in human trials comes from none of them, and the top cancer-AI company hasn't dosed a patient yet.
In this episode:
Google: DeepSomatic found 10 new mutations in childhood leukemia samples; an NHS mammography AI caught 25% of missed interval cancers across 125,000 women.
Microsoft: GigaTIME turns a $5 pathology slide into a tumour immune map across 24 cancer types.
Anthropic: Claude designed working protein binders for 14 of 15 targets, including cancer targets. Lab tests only; Claude Science launched in June.
Isomorphic Labs: cancer-first pipeline, no human trial yet, valuation talks at $40-50B.
Insilico: AI-discovered rentosertib for incurable lung fibrosis is in a 320-patient Phase III.
OpenAI & Biohub: GPT-Rosalind for drug discovery; a $1.8B virtual-cell effort with DeepMind and Meta.
The translation ladder: none of the AI-discovered treatments covered is approved yet.
🤝 Advertise on AI Unraveled & DjamgaMind: Put your enterprise AI brand in front of the CTOs, CISOs and engineering leaders who make AI buying decisions. Daily, in English and French, across 6 podcast feeds, YouTube and Substack. Sponsorship tiers & media kit: https://djamgamind.com/partners
Podden och tillhörande omslagsbild på den här sidan tillhör
Etienne Noumen. Innehållet i podden är skapat av Etienne Noumen och inte av,
eller tillsammans med, Poddtoppen.